Integral Health Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

  • $850 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$27.57 - $32.91 $4 Million - $4.77 Million
145,000 Added 193.33%
220,000 $6.07 Million
Q2 2023

Aug 11, 2023
SELL
$29.91 - $38.73 $1.5 Million - $1.94 Million
-50,000 Reduced 40.0%
75,000 $2.25 Million
Q1 2023

May 09, 2023
BUY
$34.93 - $42.03 $2.97 Million - $3.57 Million
85,000 Added 212.5%
125,000 $4.53 Million
Q4 2022

Feb 13, 2023
BUY
$31.09 - $37.88 $1.24 Million - $1.52 Million
40,000 New
40,000 $1.43 Million

Others Institutions Holding SUPN

# of Institutions
286
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.14B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email